Communiqués Nuformix plc

Actions

Temps Différé London S.E. 14:24:12 24/08/2026			Varia. 5j.	Varia. 1 janv.
0,1646 ^GBX	-0,24%		+8,65%	-35,45%

19/08	L'action Nuformix bondit après des études précliniques positives contre la fibrose	AN
19/08	Les bourses reculent, plombées par les tensions au Moyen-Orient	AN

23/05/25	Nuformix : Prospectus	PU
05/10/23	Nuformix to fund its unlicensed programs with NXP001 windfall	AQ
20/12/22	Nuformix hoping to "initiate discussions with major pharma" in 2023	AQ
20/12/22	Nuformix hoping to 'initiate discussions with major pharma' in 2023	EQ
18/02/20	Nuformix : Appointment of Dr Karl Keegan	PU
05/02/20	Nuformix : Operational Update	PU
05/02/20	Nuformix : Resignation of Dave Tapolczay	PU
28/08/18	Nuformix : Renewal of Loan Notes	PU
16/08/18	Nuformix : 2018 Annual Financial Report and Notice of Annual General Meeting	PU
15/08/18	Nuformix : Annual General Meeting – Proxy Form	PU
02/07/18	Nuformix : Operational Update	PU
11/05/18	Nuformix : appoints Dr Chris Blackwell as Non-executive Director	PU
24/04/18	Nuformix : Notification Major Interests Shares	PU
31/01/18	Nuformix : Positive Results from NXP002 Pilot Study in Lung and Liver Fibrosis	PU
22/09/17	Levrett : 22/09/17 – Report and Financial Statements For the Year Ended 31 March 2017	PU